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Abstract
In patients with community-onset acute pyelonephritis (CO-APN), assessing the risk factors for poor clinical response after 72 h of
antibiotic treatment (early clinical failure) is important. The objectives of this study were to deﬁne those risk factors, and to assess whether
early clinical failure inﬂuences mortality and treatment outcomes. We prospectively collected the clinical and microbiological data of women
with CO-APN in South Korea from March 2010 to February 2012. The numbers of cases in the early clinical success and early clinical failure
groups were 840 (79.1%) and 222 (20.9%), respectively. Final clinical failure and mortality were higher in the early clinical failure group than
in the early clinical success group (14.9% vs 2.3%, p <0.001; 6.8% vs 0.1%, p 0.001, respectively). In a multiple logistic regression model, the
risk factors for early clinical failure among the total 1062 patients were diabetes mellitus (OR 1.5; 95% CI 1.1–2.1), chronic liver diseases
(OR 3.3; 95% CI 1.6–6.7), malignancy (OR 2.2; 95% CI 1.1–4.4), Pitt score ≥2 (OR 2.5; 95% CI 1.6–3.8), presence of azotaemia (OR 1.8; 95%
CI 1.2–2.7), white blood cell count ≥20 000/mm3 (OR 2.5; 95% CI 1.6–4.0), serum C-reactive protein level ≥20 mg/dL (OR 1.7; 95% CI 1.2–
2.4), and history of antibiotic usage within the previous year (OR 1.5; 95% CI 1.1–2.2). Analysing the subgroup of 743 patients with CO-APN
due to Enterobacteriaceae, ﬂuoroquinolone resistance of the uropathogen was another factor associated with early clinical failure (OR 1.7;
95% CI 1.1–2.5). Simple variables of underlying diseases, previous antibiotic usage and initial laboratory test outcomes can be used to decide
on the direction of treatment in CO-APN.
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Abstract
It is not clear if patients with heterogeneous intermediate resistance to vancomycin (hVISA) infectious endocarditis (IE) differ from
methicillin-resistant S. aureus (MRSA) IE patients. All cases of hVISA and MRSA IE diagnosed at the Sheba Medical Centre from 2003 to 2010
were included. Isolates were screened prospectively for hVISA. Medical records were reviewed. The t-test, chi-square test, Fisher exact test
and Kaplan Meier analysis were used. Fourteen hVISA IE and 32 MRSA IE were identiﬁed. The mean age was 76 years, mean Charlson score
was 4.5 and 24% of patients had prosthetic valves. Pacemakers and implantable cardioverter-deﬁbrillators (P/ICDs) were more common in
the hVISA group (50% vs. 22%, p 0.05). P/ICDs IE occurred in 29% of hVISA patients vs. 6.3% of MRSA patients (p 0.06). hVISA patients had
more positive blood cultures (eight vs. ﬁve, p 0.007) and a trend toward longer bacteraemia (15 vs. 7.5 days, p 0.08). Vancomycin minimal
inhibitory concentrations (MICs) were similar in the two groups (1.5 lg/mL vs. 1.1 lg/mL, p 0.11). The MIC to daptomycin was higher in
hVISA (0.75 lg/mL vs. 0.32 lg/mL, p 0.049). MRSA patients received vancomycin. hVISA patients were switched to other antibiotics.
Cardiac surgery and/or P/ICD extraction was performed more commonly in hVISA patients (50% vs. 16%, p 0.027). Mortality was high in
both groups (57–66%). The median time to death was 39 days in the hVISA group and 19 days in the MRSA group (p 0.3). hVISA IE is
associated with P/ICDs. Both hVISA and MRSA are associated with high mortality. Low rates of surgical intervention and P/ICD extraction
reﬂect the high co-morbidity of patients. Caution should be employed in the empirical use of daptomycin in hVISA patients.
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Abstract
The practice of an infectious diseases (ID) physician is evolving. A contemporary understanding of the frequency and variety of patients
and syndromes seen by ID services has implications for training, service development and setting research priorities. We performed a
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2-week prospective survey of formal ID physician activities related to direct inpatient care, encompassing 53 hospitals throughout
Australia, New Zealand and Singapore, and documented 1722 inpatient interactions. Infections involving the skin and soft tissue,
respiratory tract and bone/joints together accounted for 49% of all consultations. Suspected/conﬁrmed pathogens were primarily
bacterial (60%), rather than viral (6%), fungal (4%), mycobacterial (2%) or parasitic (1%). Staphylococcus aureus was implicated in 409
(24%) episodes, approximately four times more frequently than the next most common pathogen. The frequency of healthcare-related
infections (35%), immunosuppression (21%), diabetes mellitus (19%), prosthesis-related infections (13%), multiresistant pathogens (13%)
and non-infectious diagnoses (9%) was high, although consultation characteristics varied between geographical settings and hospital
types. Our study highlights the diversity of inpatient-related ID activities and should direct future teaching and research. ID physicians’
ability to offer beneﬁcial consultative advice requires broad understanding of, and ability to interact with, a wide range of referring
specialities.
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Abstract
Susceptibility to invasive pneumococcal disease (IPD) correlates with age, younger children being the group with the highest burden of
disease. The relevance of the innate immune response and particularly the role of mannose-binding lectin (MBL) in combating IPD is
not well known. This is a 2-year prospective study (February 2011 to March 2013) including patients with IPD who attended two
hospitals from Catalonia, Spain. Variables including attack rate of pneumococcal serotype (high or low invasive potential serotypes) and
genotypes associated with low serum MBL levels were recorded. One hundred and forty-seven patients were included in the study.
One hundred and two (69.4%) patients were children or adolescents <18 years and 45 (30.6%) were adults. Overall, low-MBL
genotypes (O/O; XA/O) were detected in 23 (15.6%) patients. Children <2 years showed a higher frequency of low-MBL genotypes
compared with other patients (31.0% vs. 11.9%; p = 0.031). Further sub-analysis revealed a higher proportion of low-MBL genotypes in
children <2 years with IPD caused by opportunistic or low-attack-rate serotypes when compared with older patients (46.2% vs. 13.2%;
p = 0.02). However, no statistically signiﬁcant differences between the two groups were observed when including patients infected
with invasive or high-attack-rate serotypes (18.8% vs. 10.0%; p = 0.59). Our data suggest that young children with a genetically
determined low-MBL production are at a higher risk of developing IPD, particularly that caused by opportunistic or low-attack-rate
pneumococcal serotypes.
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Abstract
Traveller’s diarrhoea (TD) is the most common illness reported in international travellers. TD is caused by a wide range of pathogens,
including bacteria, viruses and parasites. Multiplex PCR assays can be especially useful for studying the aetiology of TD. The ﬁrst objective of
this study was to evaluate the utility of the commercially available multiplex PCR (xTAG Gastrointestinal Pathogen Panel (GPP)) for the
diagnosis of TD. A total of 185 stool specimens obtained from 174 patients were processed using the GPP assay. This test detected 86
pathogens in 67 stool samples (67/185, 36.2%). Sixteen pathogens out of 86 were also detected by routine testing. The remaining pathogens
(n = 70) required further conﬁrmation by alternative techniques. Finally, 60 out of 70 pathogens were conﬁrmed. The second objective of
this study was to analyse the aetiology of TD based on the results obtained by the GPP test and routine methods. The primary pathogens
causing TD were Shigella (24.2%) followed by enterotoxigenic Escherichia coli (ETEC) (23.2%), enteroaggregative E. coli (14.7%) and Giardia
(13.7%). Signiﬁcant regional differences were observed for ETEC with 19.4% of TD cases acquired in Africa, 11.3% in Asia and none in South
Central (SC) America (p 0.01), Giardia was found in 1.5% of cases among those who had travelled to Africa, 14.1% of those who had
travelled to Asia and 3% of those who had travelled to SC America (p 0.01). In conclusion, the GPP test improved the detection of
enteropathogens and allowed better assessment of the aetiology of TD.
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